Get the app
US › Healthcare

Abivax SA American Depositary Shares (ABVX)

US · Healthcare · Biotechnology

$106.99+4.66%
Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-48.5M
EPS
$-0.71
EPS estimate
$-0.81

EPS came in at -0.71 against a street estimate of -0.81 — a beat of 12.3%.

Key statistics

Market cap
$8.92B
Forward P/E
0.0
P/B
18.69
Book value
$6.25
EPS (TTM)
$-5.12
52-week high
$148.83
52-week low
$69.81
50-day MA
$124.06
200-day MA
$119.26
Beta
-0.25

Analyst view

Analysts rate Abivax SA American Depositary Shares a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $165.00.

Shareholding

Institutions
72.00%

Largest institutional holders

FundStake
TCG Crossover Management, LLC6.89%
UBS Group AG5.21%
Darwin Global Management, Ltd.4.15%
Helikon Investments Ltd3.19%
Morgan Stanley - Brokerage Accounts1.95%
Caligan Partners LP1.79%
Vestal Point Capital LP1.72%
Citadel Advisors Llc1.65%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Abivax SA American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.